| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | Id |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1235.350/expansion |
| Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.350 |
| Version | 20230808 |
| Status | active |
| Date | 2023-08-08T01:00:54-04:00 |
| Name | COVID19Vaccine_EventClinicalGrouping |
| Title | COVID19 Vaccine_Event Clinical Grouping |
| Experimental | False |
| Realm | us |
| Authority | hl7 |
| Description | b.well created value set by Sr. Clinical Business Analyst for the COVID19 Vaccine_Event Clinical Grouping. |
| Purpose | (Clinical Focus: This value set's intent is to define the clinical codes that constitute the COVID19 Vaccine_Event Clinical Grouping and utilization in patients/users connected health.),(Data Element Scope: This value set's intent is to define the clinical codes that constitute the COVID19 Vaccine_Event Clinical Grouping and utilization in patients/users connected health.),(Inclusion Criteria: This value set's intent is to define the clinical codes that constitute the COVID19 Vaccine_Event Clinical Grouping and utilization in patients/users connected health.),(Exclusion Criteria: This value set's intent is to define the clinical codes that constitute the COVID19 Vaccine_Event Clinical Grouping and utilization in patients/users connected health.) |
No resources found
| CodeSystem | |
http://www.ama-assn.org/go/cpt  | Current Procedural Terminology (CPT®) |
| http://hl7.org/fhir/sid/cvx | Vaccine Administered Code Set (CVX) |
| http://www.nlm.nih.gov/research/umls/rxnorm | RxNorm |
| http://hl7.org/fhir/sid/cvx | Vaccine Administered Code Set (CVX) |
| http://hl7.org/fhir/sid/cvx | CVX codes used in this IG |
| http://www.ama-assn.org/go/cpt | Current Procedural Terminology (CPT®) |
| http://www.nlm.nih.gov/research/umls/rxnorm | RxNorm |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.345 | COVID19 Vaccine_CPT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.346 | COVID19 Vaccine_HCPCS |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.348 | COVID19 Vaccine_RxNorm |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.349 | COVID19 Vaccine_CVX |
FHIR{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113762.1.4.1235.350",
"meta" : {
"versionId" : "6",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "B.well Connected Health Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-09-24"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2023-08-08"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.350",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1235.350"
}
],
"version" : "20230808",
"name" : "COVID19Vaccine_EventClinicalGrouping",
"title" : "COVID19 Vaccine_Event Clinical Grouping",
"status" : "active",
"date" : "2023-08-08T01:00:54-04:00",
"publisher" : "B.well Connected Health Steward",
"description" : "b.well created value set by Sr. Clinical Business Analyst for the COVID19 Vaccine_Event Clinical Grouping.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: This value set's intent is to define the clinical codes that constitute the COVID19 Vaccine_Event Clinical Grouping and utilization in patients/users connected health.),(Data Element Scope: This value set's intent is to define the clinical codes that constitute the COVID19 Vaccine_Event Clinical Grouping and utilization in patients/users connected health.),(Inclusion Criteria: This value set's intent is to define the clinical codes that constitute the COVID19 Vaccine_Event Clinical Grouping and utilization in patients/users connected health.),(Exclusion Criteria: This value set's intent is to define the clinical codes that constitute the COVID19 Vaccine_Event Clinical Grouping and utilization in patients/users connected health.)",
"compose" : {
"include" : [
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.345"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.346"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.348"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.349"
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:00528008-aa36-4923-a542-9460faecb4c9",
"timestamp" : "2024-12-10T08:51:25-05:00",
"total" : 28,
"contains" : [
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "207",
"display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "208",
"display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "210",
"display" : "SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "211",
"display" : "SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "212",
"display" : "SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "217",
"display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "218",
"display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "219",
"display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "221",
"display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "227",
"display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "228",
"display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "229",
"display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "230",
"display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2468235",
"display" : "SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML Injectable Suspension"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2470234",
"display" : "SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML Injectable Suspension"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2479835",
"display" : "SARS-COV-2 (COVID-19) vaccine, vector - Ad26 100000000000 UNT/ML Injectable Suspension"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "300",
"display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "301",
"display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "302",
"display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "502",
"display" : "SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN)"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "506",
"display" : "SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "510",
"display" : "SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm)"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "511",
"display" : "SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac)"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "518",
"display" : "SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "519",
"display" : "SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna"
},
{
"system" : "http://hl7.org/fhir/sid/cvx",
"version" : "20240905",
"code" : "520",
"display" : "SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech"
},
{
"system" : "http://www.ama-assn.org/go/cpt",
"version" : "2025",
"code" : "91304",
"display" : "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, 5 mcg/0.5 mL dosage, for intramuscular use"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"version" : "2024",
"code" : "91304",
"display" : "Severe acute respiratory syndrome coronavirus 2 (COVID-19) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage, for intramuscular use"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.